FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018553516> ?p ?o ?g. }

• W2018553516 endingPage "e56837" @default.
• W2018553516 startingPage "e56837" @default.
• W2018553516 abstract "Posterior capsular opacification (PCO) is a common complication of cataract surgery. Transforming growth factor-β2 (TGF-β2) plays important roles in the development of PCO. The existing pharmacological treatments are not satisfactory and can have toxic side effects.We evaluated the effect of pirfenidone on proliferation, migration and epithlial-mesenchymal transition of human lens epithelial cell line SRA01/04 (HLECs) in vitro. After treatment with 0, 0.25, and 0.5 mg/ml pirfenidone, cell proliferation was measured by MTT assay. Cell viability was determined by trypan blue exclusion assay and measurement of lactate dehydrogenase (LDH) activity released from the damaged cells. And cell migration was measured by scratch assay in the absence or presence of transforming growth factor-β2 (TGF-β2). The expressions of TGF-β2 and SMADs were evaluated with real-time RT-PCR, western blot, and immunofluorescence analyses. The mesenchymal phenotypic marker fibronectin (FN) was demonstrated by Immunocytofluorescence analyses. The cells had high viability, which did not vary across different concentrations of pirfenidone (0 [control] 0.3, 0.5 or 1.0 mg/ml) after 24 hours. Pirfenidone (0∼0.5 mg/ml) had no significant cytotoxicity effect on SRA01/04 by LDH assay. Pirfenidone significantly inhibited the proliferation and TGF-β2-induced cell migration and the effects were dose-dependent, and inhibited TGF-β2-induced fibroblastic phenotypes and TGF-β2-induced expression of FN in SRA01/04 cells. The cells showed dose-dependent decreases in mRNA and protein levels of TGF-β2 and SMADs. Pirfenidone also depressed the TGF-β2-induced expression of SMADs and blocked the nuclear translocation of SMADs in cells.Pirfenidone inhibits TGF-β2-induced proliferation, migration and epithlial-mesenchymal transition of human lens epithelial cells line SRA01/04 at nontoxic concentrations. This effect may be achieved by down regulation of TGF-β/SAMD signaling in SRA01/04 cells." @default.
• W2018553516 created "2016-06-24" @default.
• W2018553516 creator A5000076506 @default.
• W2018553516 creator A5033314475 @default.
• W2018553516 creator A5046082086 @default.
• W2018553516 creator A5072095183 @default.
• W2018553516 creator A5083220985 @default.
• W2018553516 date "2013-02-21" @default.
• W2018553516 modified "2023-09-24" @default.
• W2018553516 title "Inhibition of Pirfenidone on TGF-beta2 Induced Proliferation, Migration and Epithlial-Mesenchymal Transition of Human Lens Epithelial Cells Line SRA01/04" @default.
• W2018553516 cites W1965185650 @default.
• W2018553516 cites W1970441910 @default.
• W2018553516 cites W1976957021 @default.
• W2018553516 cites W1996605292 @default.
• W2018553516 cites W2013095759 @default.
• W2018553516 cites W2018659066 @default.
• W2018553516 cites W2028494744 @default.
• W2018553516 cites W2029181407 @default.
• W2018553516 cites W2030837762 @default.
• W2018553516 cites W2031374932 @default.
• W2018553516 cites W2033728382 @default.
• W2018553516 cites W2035653659 @default.
• W2018553516 cites W2040923898 @default.
• W2018553516 cites W2059988298 @default.
• W2018553516 cites W2062387633 @default.
• W2018553516 cites W2068774044 @default.
• W2018553516 cites W2113481335 @default.
• W2018553516 cites W2114522026 @default.
• W2018553516 cites W2150361016 @default.
• W2018553516 cites W2171180036 @default.
• W2018553516 cites W4249588491 @default.
• W2018553516 doi "https://doi.org/10.1371/journal.pone.0056837" @default.
• W2018553516 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3578851" @default.
• W2018553516 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23437252" @default.
• W2018553516 hasPublicationYear "2013" @default.
• W2018553516 type Work @default.
• W2018553516 sameAs 2018553516 @default.
• W2018553516 citedByCount "47" @default.
• W2018553516 countsByYear W20185535162014 @default.
• W2018553516 countsByYear W20185535162015 @default.
• W2018553516 countsByYear W20185535162016 @default.
• W2018553516 countsByYear W20185535162017 @default.
• W2018553516 countsByYear W20185535162018 @default.
• W2018553516 countsByYear W20185535162019 @default.
• W2018553516 countsByYear W20185535162020 @default.
• W2018553516 countsByYear W20185535162021 @default.
• W2018553516 countsByYear W20185535162022 @default.
• W2018553516 countsByYear W20185535162023 @default.
• W2018553516 crossrefType "journal-article" @default.
• W2018553516 hasAuthorship W2018553516A5000076506 @default.
• W2018553516 hasAuthorship W2018553516A5033314475 @default.
• W2018553516 hasAuthorship W2018553516A5046082086 @default.
• W2018553516 hasAuthorship W2018553516A5072095183 @default.
• W2018553516 hasAuthorship W2018553516A5083220985 @default.
• W2018553516 hasBestOaLocation W20185535161 @default.
• W2018553516 hasConcept C104317684 @default.
• W2018553516 hasConcept C118131993 @default.
• W2018553516 hasConcept C126322002 @default.
• W2018553516 hasConcept C127561419 @default.
• W2018553516 hasConcept C137738243 @default.
• W2018553516 hasConcept C1491633281 @default.
• W2018553516 hasConcept C153911025 @default.
• W2018553516 hasConcept C16685009 @default.
• W2018553516 hasConcept C185592680 @default.
• W2018553516 hasConcept C198826908 @default.
• W2018553516 hasConcept C2776415932 @default.
• W2018553516 hasConcept C2777714996 @default.
• W2018553516 hasConcept C2778229498 @default.
• W2018553516 hasConcept C2778341716 @default.
• W2018553516 hasConcept C2779832356 @default.
• W2018553516 hasConcept C2780070996 @default.
• W2018553516 hasConcept C2780783641 @default.
• W2018553516 hasConcept C53227056 @default.
• W2018553516 hasConcept C54355233 @default.
• W2018553516 hasConcept C55493867 @default.
• W2018553516 hasConcept C62112901 @default.
• W2018553516 hasConcept C71924100 @default.
• W2018553516 hasConcept C76419328 @default.
• W2018553516 hasConcept C81885089 @default.
• W2018553516 hasConcept C86492073 @default.
• W2018553516 hasConcept C86803240 @default.
• W2018553516 hasConcept C95444343 @default.
• W2018553516 hasConceptScore W2018553516C104317684 @default.
• W2018553516 hasConceptScore W2018553516C118131993 @default.
• W2018553516 hasConceptScore W2018553516C126322002 @default.
• W2018553516 hasConceptScore W2018553516C127561419 @default.
• W2018553516 hasConceptScore W2018553516C137738243 @default.
• W2018553516 hasConceptScore W2018553516C1491633281 @default.
• W2018553516 hasConceptScore W2018553516C153911025 @default.
• W2018553516 hasConceptScore W2018553516C16685009 @default.
• W2018553516 hasConceptScore W2018553516C185592680 @default.
• W2018553516 hasConceptScore W2018553516C198826908 @default.
• W2018553516 hasConceptScore W2018553516C2776415932 @default.
• W2018553516 hasConceptScore W2018553516C2777714996 @default.
• W2018553516 hasConceptScore W2018553516C2778229498 @default.
• W2018553516 hasConceptScore W2018553516C2778341716 @default.
• W2018553516 hasConceptScore W2018553516C2779832356 @default.
• W2018553516 hasConceptScore W2018553516C2780070996 @default.

• next